Platelet response heterogeneity in thrombus formation. 2009

Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.

Vascular injury leads to formation of a structured thrombus as a consequence of platelet activation and aggregation, thrombin and fibrin formation, and trapping of leukocytes and red cells. This review summarises current evidence for heterogeneity of platelet responses and functions in the thrombus-forming process. Environmental factors contribute to response heterogeneity, as the platelets in a thrombus adhere to different substrates, and sense specific (ant)agonists and rheological conditions. Contraction of platelets and interaction with fibrin and other blood cells cause further response variation. On the other hand, response heterogeneity can also be due to intrinsic differences between platelets in age and in receptor and signalling proteins. As a result, at least three subpopulations of platelets are formed in a thrombus: aggregating platelets with (reversible) integrin activation, procoagulant (coated) platelets exposing phosphatidylserine and binding coagulation factors, and contracting platelets with cell-cell contacts. This recognition of thrombus heterogeneity has implications for the use and development of antiplatelet medication.

UI MeSH Term Description Entries
D008955 Models, Cardiovascular Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment. Cardiovascular Model,Cardiovascular Models,Model, Cardiovascular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D016922 Cellular Senescence Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS. Aging, Cell,Cell Aging,Cell Senescence,Replicative Senescence,Senescence, Cellular,Senescence, Replicative,Cell Ageing,Cellular Ageing,Cellular Aging,Ageing, Cell,Ageing, Cellular,Aging, Cellular,Senescence, Cell
D018056 Hemorheology The deformation and flow behavior of BLOOD and its elements i.e., PLASMA; ERYTHROCYTES; WHITE BLOOD CELLS; and BLOOD PLATELETS. Hemorrheology

Related Publications

Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
May 2003, Nihon rinsho. Japanese journal of clinical medicine,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
July 2009, Journal of thrombosis and haemostasis : JTH,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
January 1983, British journal of clinical pharmacology,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
July 1997, Thrombosis and haemostasis,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
February 2011, Journal of molecular medicine (Berlin, Germany),
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
January 1974, Schweizerische medizinische Wochenschrift,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
September 1996, Rinsho byori. The Japanese journal of clinical pathology,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
August 2017, International journal of molecular sciences,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
July 2006, Journal of thrombosis and haemostasis : JTH,
Imke C A Munnix, and Judith M E M Cosemans, and Jocelyn M Auger, and Johan W M Heemskerk
February 1994, Circulation,
Copied contents to your clipboard!